nodes	percent_of_prediction	percent_of_DWPC	metapath
Acarbose—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.0349	0.0349	CcSEcCtD
Acarbose—Intestinal obstruction—Vincristine—lymphatic system cancer	0.0331	0.0331	CcSEcCtD
Acarbose—Ileus—Vincristine—lymphatic system cancer	0.0318	0.0318	CcSEcCtD
Acarbose—Jaundice—Mechlorethamine—lymphatic system cancer	0.031	0.031	CcSEcCtD
Acarbose—Liver function test abnormal—Teniposide—lymphatic system cancer	0.0281	0.0281	CcSEcCtD
Acarbose—Intestinal perforation—Methotrexate—lymphatic system cancer	0.0277	0.0277	CcSEcCtD
Acarbose—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.0247	0.0247	CcSEcCtD
Acarbose—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.0199	0.0199	CcSEcCtD
Acarbose—Liver disorder—Methotrexate—lymphatic system cancer	0.016	0.016	CcSEcCtD
Acarbose—Liver function test abnormal—Carmustine—lymphatic system cancer	0.0158	0.0158	CcSEcCtD
Acarbose—Oedema—Teniposide—lymphatic system cancer	0.015	0.015	CcSEcCtD
Acarbose—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.015	0.015	CcSEcCtD
Acarbose—Thrombocytopenia—Teniposide—lymphatic system cancer	0.0147	0.0147	CcSEcCtD
Acarbose—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0139	0.0139	CcSEcCtD
Acarbose—Oedema—Fludarabine—lymphatic system cancer	0.0132	0.0132	CcSEcCtD
Acarbose—Vomiting—Mechlorethamine—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Acarbose—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Acarbose—Rash—Mechlorethamine—lymphatic system cancer	0.0128	0.0128	CcSEcCtD
Acarbose—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0128	0.0128	CcSEcCtD
Acarbose—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Acarbose—Nausea—Mechlorethamine—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Acarbose—Jaundice—Mitoxantrone—lymphatic system cancer	0.012	0.012	CcSEcCtD
Acarbose—Urticaria—Teniposide—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Acarbose—Abdominal pain—Teniposide—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Acarbose—Erythema—Bleomycin—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Acarbose—Dyspepsia—Fludarabine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Acarbose—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Acarbose—Constipation—Fludarabine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Acarbose—Hypersensitivity—Teniposide—lymphatic system cancer	0.011	0.011	CcSEcCtD
Acarbose—Hepatitis—Mitoxantrone—lymphatic system cancer	0.011	0.011	CcSEcCtD
Acarbose—Erythema—Carmustine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Acarbose—Angiopathy—Vincristine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Acarbose—Diarrhoea—Teniposide—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Acarbose—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0097	0.0097	CcSEcCtD
Acarbose—Oedema—Bleomycin—lymphatic system cancer	0.00965	0.00965	CcSEcCtD
Acarbose—Erythema—Mitoxantrone—lymphatic system cancer	0.00959	0.00959	CcSEcCtD
Acarbose—Vomiting—Teniposide—lymphatic system cancer	0.00952	0.00952	CcSEcCtD
Acarbose—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00945	0.00945	CcSEcCtD
Acarbose—Rash—Teniposide—lymphatic system cancer	0.00944	0.00944	CcSEcCtD
Acarbose—Dermatitis—Teniposide—lymphatic system cancer	0.00943	0.00943	CcSEcCtD
Acarbose—Diarrhoea—Fludarabine—lymphatic system cancer	0.009	0.009	CcSEcCtD
Acarbose—Nausea—Teniposide—lymphatic system cancer	0.00889	0.00889	CcSEcCtD
Acarbose—Oedema—Carmustine—lymphatic system cancer	0.00842	0.00842	CcSEcCtD
Acarbose—Vomiting—Fludarabine—lymphatic system cancer	0.00837	0.00837	CcSEcCtD
Acarbose—Rash—Fludarabine—lymphatic system cancer	0.0083	0.0083	CcSEcCtD
Acarbose—Dermatitis—Fludarabine—lymphatic system cancer	0.00829	0.00829	CcSEcCtD
Acarbose—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00825	0.00825	CcSEcCtD
Acarbose—Oedema—Vincristine—lymphatic system cancer	0.00804	0.00804	CcSEcCtD
Acarbose—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00787	0.00787	CcSEcCtD
Acarbose—Oedema—Mitoxantrone—lymphatic system cancer	0.00783	0.00783	CcSEcCtD
Acarbose—Nausea—Fludarabine—lymphatic system cancer	0.00782	0.00782	CcSEcCtD
Acarbose—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00767	0.00767	CcSEcCtD
Acarbose—Urticaria—Bleomycin—lymphatic system cancer	0.00766	0.00766	CcSEcCtD
Acarbose—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00733	0.00733	CcSEcCtD
Acarbose—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00727	0.00727	CcSEcCtD
Acarbose—Constipation—Carmustine—lymphatic system cancer	0.0072	0.0072	CcSEcCtD
Acarbose—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00711	0.00711	CcSEcCtD
Acarbose—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00694	0.00694	CcSEcCtD
Acarbose—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00689	0.00689	CcSEcCtD
Acarbose—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00689	0.00689	CcSEcCtD
Acarbose—Constipation—Vincristine—lymphatic system cancer	0.00688	0.00688	CcSEcCtD
Acarbose—Constipation—Mitoxantrone—lymphatic system cancer	0.0067	0.0067	CcSEcCtD
Acarbose—Abdominal pain—Carmustine—lymphatic system cancer	0.00666	0.00666	CcSEcCtD
Acarbose—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00657	0.00657	CcSEcCtD
Acarbose—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.0064	0.0064	CcSEcCtD
Acarbose—Abdominal pain—Vincristine—lymphatic system cancer	0.00636	0.00636	CcSEcCtD
Acarbose—Urticaria—Mitoxantrone—lymphatic system cancer	0.00622	0.00622	CcSEcCtD
Acarbose—Hypersensitivity—Carmustine—lymphatic system cancer	0.0062	0.0062	CcSEcCtD
Acarbose—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00619	0.00619	CcSEcCtD
Acarbose—Vomiting—Bleomycin—lymphatic system cancer	0.00613	0.00613	CcSEcCtD
Acarbose—Rash—Bleomycin—lymphatic system cancer	0.00608	0.00608	CcSEcCtD
Acarbose—Dermatitis—Bleomycin—lymphatic system cancer	0.00608	0.00608	CcSEcCtD
Acarbose—Hypersensitivity—Vincristine—lymphatic system cancer	0.00592	0.00592	CcSEcCtD
Acarbose—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00578	0.00578	CcSEcCtD
Acarbose—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Acarbose—Diarrhoea—Carmustine—lymphatic system cancer	0.00576	0.00576	CcSEcCtD
Acarbose—Nausea—Bleomycin—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Acarbose—Diarrhoea—Vincristine—lymphatic system cancer	0.0055	0.0055	CcSEcCtD
Acarbose—Hepatitis—Methotrexate—lymphatic system cancer	0.00549	0.00549	CcSEcCtD
Acarbose—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Acarbose—Vomiting—Carmustine—lymphatic system cancer	0.00535	0.00535	CcSEcCtD
Acarbose—Rash—Carmustine—lymphatic system cancer	0.00531	0.00531	CcSEcCtD
Acarbose—Dermatitis—Carmustine—lymphatic system cancer	0.00531	0.00531	CcSEcCtD
Acarbose—Vomiting—Vincristine—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Acarbose—Rash—Vincristine—lymphatic system cancer	0.00507	0.00507	CcSEcCtD
Acarbose—Dermatitis—Vincristine—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Acarbose—Nausea—Carmustine—lymphatic system cancer	0.005	0.005	CcSEcCtD
Acarbose—Angiopathy—Methotrexate—lymphatic system cancer	0.00498	0.00498	CcSEcCtD
Acarbose—Vomiting—Mitoxantrone—lymphatic system cancer	0.00498	0.00498	CcSEcCtD
Acarbose—Immune system disorder—Methotrexate—lymphatic system cancer	0.00496	0.00496	CcSEcCtD
Acarbose—Rash—Mitoxantrone—lymphatic system cancer	0.00494	0.00494	CcSEcCtD
Acarbose—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00493	0.00493	CcSEcCtD
Acarbose—Erythema—Methotrexate—lymphatic system cancer	0.00478	0.00478	CcSEcCtD
Acarbose—Nausea—Vincristine—lymphatic system cancer	0.00478	0.00478	CcSEcCtD
Acarbose—Nausea—Mitoxantrone—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Acarbose—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Acarbose—Dyspepsia—Methotrexate—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Acarbose—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Acarbose—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Acarbose—Urticaria—Methotrexate—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Acarbose—Abdominal pain—Methotrexate—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Acarbose—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Acarbose—Diarrhoea—Methotrexate—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Acarbose—Vomiting—Methotrexate—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Acarbose—Rash—Methotrexate—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Acarbose—Dermatitis—Methotrexate—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Acarbose—Nausea—Methotrexate—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
